In our study, EDTA, MMP specific inhibitors and doxycyline inhibited MMP-9 and to a lesser extent MMP-8 activity, suggesting that strategies utilizing small molecule agents to restore MMP regulation may retain activity in the ARDS environment. The gene discussed is MMP8; the disease is acute respiratory distress syndrome.